CJC-1295
Also known as: CJC-1295 with DAC, CJC-1295 without DAC, Modified GRF (1-29), Mod GRF 1-29, DAC:GRF, tetrasubstituted GRF(1-29)
CJC-1295 is a synthetic peptide modeled on the first 29 amino acids of human growth hormone-releasing hormone (GHRH). It exists in two forms. One version, often called CJC-1295 with DAC, adds a drug affinity complex that binds to blood albumin to extend its half-life. The other, sometimes labeled CJC-1295 without DAC or Modified GRF (1-29), lacks that modification and acts for a much shorter time. It is a research compound and is not a licensed pharmaceutical product.
Often sold in blends: CJC-1295 / Ipamorelin.
How it works
Research describes CJC-1295 as a GHRH receptor agonist that acts on the pituitary gland to stimulate the release of the body's own growth hormone, which in turn can raise levels of insulin-like growth factor 1 (IGF-1). The DAC modification is reported to bind albumin so the peptide stays in circulation longer than native GHRH. These mechanisms are drawn from early pharmacology studies, and the compound's clinical usefulness has not been established.
Researched uses
- Studied for its effect on growth hormone secretion in healthy adults
- Studied for its effect on IGF-1 levels in early-phase trials
- Studied for HIV-associated lipodystrophy in a discontinued development program
- Investigated as a research tool for understanding GHRH signaling
- Explored in fitness and anti-aging contexts, though without controlled clinical support
CJC-1295 is not FDA-approved for any use, and there is no branded prescription product. It has no recognized USP monograph and is not an approved medicine. It was nominated for the FDA 503A list of bulk drug substances for compounding but was placed in Category 2, and its status has been the subject of regulatory review and litigation rather than affirmative approval for compounding. It has not been moved to the list of substances permitted for compounding. Material sold online as CJC-1295 "for research use only" is not a regulated medicine and falls outside the licensed pharmacy system. It is also prohibited in sport under World Anti-Doping Agency rules.
CJC-1295 providers compared
Providers that have passed our rubric review are listed first, then ordered by the total cost of a 3-month protocol. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the headline figure folds in any one-time consult or provider-review fee plus three months of membership. Use the calculator below to adjust the length and see the same total broken out.
| Provider | Sourcing | What's included | Verified | Visit provider | |
|---|---|---|---|---|---|
| No provider in this directory currently lists a published price for this drug. | |||||
We average every cost to a standard 3-month protocol, which our medical advisors consider the best window for comparing cost and value. Monthly plans are multiplied by 3 and 3-month programs are taken as billed; each provider's own sticker price and cadence are shown underneath.
The headline figure is the total 3-month cost: the medication plus any one-time consult or provider-review fee (for example RxPepsDirect's $39) and three months of any membership fee. Where a fee is not published we fold in what is known and flag that other fees may apply.
Per-vial providers are averaged to a 3-month protocol at roughly one vial per month (3 vials), marked "est.", with the per-vial price shown underneath. Actual vial count depends on your dose and protocol.
Prices are gathered from each provider's public pages. The "Verified" date is when we last checked the provider's sticker price; for per-vial providers it is the vial price that was verified, not the averaged 3-month total.
Safety notes
Published early-phase trials reported that single doses were generally tolerated, with injection site reactions noted as the most common effect. Long-term controlled human safety data are lacking, and effects such as water retention, tingling, flushing, and changes in blood sugar have been discussed in the context of growth hormone pathway stimulation. Because CJC-1295 is not made within the licensed pharmacy system, the identity, purity, dose, and sterility of products sold as CJC-1295 are not verified and can vary widely. Anyone considering it should consult a qualified clinician.
CJC-1295 questions
How much does CJC-1295 cost?
No licensed provider in this directory currently publishes a price for CJC-1295. This page will list verified prices with their sources if that changes.
Is CJC-1295 an FDA-approved medication?
No. CJC-1295 is not FDA-approved for any condition, and there is no branded prescription version. It is an investigational research compound, and its human clinical usefulness has not been established.
How is CJC-1295 typically administered?
In research settings it has been given as a subcutaneous injection. This is a general description of the route used in studies and is not guidance on use. There are no approved dosing instructions for CJC-1295.
How can someone obtain CJC-1295 and what does that involve?
There is no approved commercial product. Material sold online as CJC-1295 for research use is unregulated and sits outside the licensed pharmacy system, so its contents and quality are not verified. Questions about access, legality, and cost are best directed to a licensed clinician or pharmacist.
Related reading
- Peptide Therapy vs TRT: An Honest ComparisonAn independent, evidence-honest look at how TRT and peptide therapy differ on FDA status, research, fertility, safety, and finding legal, prescription-based care.
- How to Get Peptides Safely and LegallyHow to get peptides through the legal, licensed pathway: prescriptions, 503A/503B pharmacies, honest evidence, and how to avoid the research-use-only gray market.
- Is Peptide Therapy Right for You?An independent guide to weighing peptide therapy: legality, what the research actually shows, who should avoid it, and how to find safe, licensed care.
- Peptides Studied for Energy and PerformanceAn independent look at CJC-1295, ipamorelin, and MOTS-c for energy and performance: what the research shows, safety and legality, and how to find licensed care.
- Peptides Studied for Longevity and Anti-AgingAn independent look at peptides studied for longevity (GHK-Cu, epithalon, MOTS-c, humanin), what the research shows, and how to find safe, legal care.
- Peptide Access in 2026: What's Legal, What's RestrictedAn independent look at peptide access in 2026: which compounds are legal, which are restricted, what the evidence shows, and how to find licensed treatment.
- Peptide Therapy Side Effects: An Evidence-Based GuideAn independent, evidence-based look at peptide therapy side effects by compound class, gray-market supply risk, and how to find safe, legal treatment.